Fact CheckerSign in

NCT07005089Completed

Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts

Diagnostic Accuracy of Ultrasound and Tumors Markers in Diagnosis of Complex Ovarian Cysts in Adolescent, Histopathological Correlation

Source: ClinicalTrials.gov · Last updated 5 Jun 2025

Brief summary (registry, in English)

Cystic ovarian lesions are more common in adolescences due to onset of hormonal activity in prepubertal age. Most cysts are functional but a malignant etiology must nevertheless always be eliminated. Most ovarian cysts in adolescents are benign in nature, with 60% being simple ovarian cysts. Cystic neoplasia may be benign, borderline, or malignant. The large majority are benign or borderline, accounting for 80% and 16%, respectively

Status (registry)
Completed
Study type
Interventional
Enrollment
48 (actual)
First submitted
27 May 2025
Start date
10 Feb 2023
Primary completion date
1 Oct 2024
Lead sponsor
Al-Azhar University
NCT number
NCT07005089

What you commit to

  • Study type: Interventional
  • Participants enrolled: 48
  • From 10 Feb 2023 to the primary completion date, 1 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any suspected ovarian malignancy

Other

  • simple ovarian cyst \< 7cm

Who the study is looking for

  • Female patients diagnosed by complex ovarian cysts

Age in the registry: 11 years to 21 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Al-Azhar University hospital
Coordinator of this site? Confirm its status
AsyutEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.